Basic Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 21, 2022; 28(31): 4310-4327
Published online Aug 21, 2022. doi: 10.3748/wjg.v28.i31.4310
Table 2 Characterization of hereditary risk group: Germline mutations and personal history of cancer, n = 20

Lynch syndrome, n = 17 (85.0%)
Peutz-Jeghers syndrome, n = 1 (5.0%)
FPC, n = 2 (10.0%)
Germline mutation(s)
MLH17 (41.2)--
MSH26 (35.3)--
MLH1 + MSH21 (5.9)--
MSH2 + MSH62 (11.7)--
MSH61 (5.9)--
STK11-1 (100.0)-
Not identified-2 (100.0)
Personal history of cancer
No11 (64.7)1 (100.0)2 (100.0)
Yes6 (35.3)0 (0.0)0 (0.0)
Type of cancer
Colon and rectum 5 (83.3%)--
Endometrium1 (16.7)--

  • Citation: Moutinho-Ribeiro P, Batista IA, Quintas ST, Adem B, Silva M, Morais R, Peixoto A, Coelho R, Costa-Moreira P, Medas R, Lopes S, Vilas-Boas F, Baptista M, Dias-Silva D, Esteves AL, Martins F, Lopes J, Barroca H, Carneiro F, Macedo G, Melo SA. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities. World J Gastroenterol 2022; 28(31): 4310-4327
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i31/4310.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i31.4310